3,3′,5-三碘-L-甲状腺素-13C6结构式
|
常用名 | 3,3′,5-三碘-L-甲状腺素-13C6 | 英文名 | Liothyronine-13C6-1 |
---|---|---|---|---|
CAS号 | 1213431-76-5 | 分子量 | 656.93 | |
密度 | N/A | 沸点 | N/A | |
分子式 | 13C6C9H12I3NO4 | 熔点 | N/A | |
MSDS | N/A | 闪点 | 9 °C | |
符号 |
GHS02, GHS06, GHS08 |
信号词 | Danger |
3,3′,5-三碘-L-甲状腺素-13C6用途内标3,3´,5--三碘-L-甲状腺原氨酸--13C6(T3-13C6)的Certified Spiking Solution®。3,3′,5-三碘-L-甲状腺原氨酸(T3)是一种甲状腺激素,参与人体生长发育、代谢、体温和心率等多种生理过程。该内标适用于LC-MS/MS法定量检测血清游离T3和总T3水平,以测定由过量T3引起的甲亢。 |
中文名 | 3,3′,5-三碘-L-甲状腺素-13C6 |
---|---|
英文名 | 3,3′,5-Triiodo-L-thyronine-13C6 solution |
描述 | Liothyronie-13C6-1是13C标记的Liothyroine。Liothyronine是一种有效的甲状腺激素受体TRα和TRβ激动剂,hTRα和hTRβ的Kis分别为2.33 nM[1][2]。 |
---|---|
相关类别 | |
参考文献 |
分子式 | 13C6C9H12I3NO4 |
---|---|
分子量 | 656.93 |
外观性状 | liquid |
符号 |
GHS02, GHS06, GHS08 |
---|---|
信号词 | Danger |
危害声明 | H225-H301 + H311 + H331-H370 |
警示性声明 | P210-P260-P280-P301 + P310-P311 |
危险品运输编码 | UN1230 - class 3 - PG 2 - Methanol, solution |
闪点(华氏) | 48.2 °F |
闪点(摄氏) | 9 °C |
Psychometric assessment of the Rat Grimace Scale and development of an analgesic intervention score.
PLoS ONE 9(5) , e97882, (2014) Our limited ability to assess spontaneous pain in rodent models of painful human conditions may be associated with a translational failure of promising analgesic compounds in to clinical use. If measu... |
|
Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: an up-to-date meta-analysis.
Crit. Rev. Oncol. Hematol. , doi:10.1016/j.critrevonc.2014.04.004, (2014) Arterial thromboembolic events (ATEs) with vascular endothelial growth factor receptor tyrosine kinase inhibitors (VEGFR-TKIs) have emerged as a serious concern, we perform a meta-analysis of randomiz... |
|
Intensity-modulated radiotherapy for stage IVA/IVB nasopharyngeal carcinoma: clinical outcomes and patterns of failure in an endemic area in China.
Strahlenther. Onkol. , (2014) The purpose of this study was to analyze the mode of relapse patterns and survival of 209 patients with stage IVA and IVB nasopharyngeal carcinoma (NPC).A total of 209 patients who underwent magnetic ... |